FDA approves two generic hypertension drugs from Mylan
PITTSBURGH — Generic drug maker Mylan has received regulatory approval for a drug used to treat high blood pressure, also known as hypertension, the company said Friday, saying that it would launch both drugs immediately.
Mylan said the Food and Drug Administration approved its irbesartan tablets in the 75 mg, 150 mg and 300 mg strengths and irbesartan and hydrochlorothiazide tablets in the 150 mg/12.5 mg and 300 mg/12.5 mg strengths. The drugs are respectively generic versions of Sanofi’s Avapro and Avalide.
Avapro is used to treat hypertension in patients with Type 2 diabetic nephropathy, while Avalide is used to treat hypertension in patents whose disease is inadequately controlled with a single drug or who are first starting therapy and need multiple drugs to control blood pressure.
Irbesartan tablets had sales of about $400.7 million during the 12-month period ending in June 2012, while irbesartan and hydrochlorothiazide tablets had sales of about $117.4 million during the same time, according to IMS Health.
Energizer introduces safe, flameless candles
ST. LOUIS — Energizer Household Lighting has introduced an innovative option for those wanting the ambiance of candles without the worry of open flames: Energizer Flameless Wax Candles.
The Flameless Wax Candles, currently available online and at mass market retailers, feature a realistic flickering LED “flame” and melted edge design at the top of the candle. A three-level timer allows the user to schedule the candle to turn off after four, six or eight hours of use; the candle also can be programmed to turn on at the same time every day.
In addition to a year-round selection of Flameless Wax Candles in various colors and designs, Energizer created a special holiday collection featuring fragrant scents, snowflake and floral designs, “JOY” votives, and red or white glitter pillars. The candles retail for $4.99 to $23.99.
FDA launches rogue pharmacy education campaign
SILVER SPRING, Md. — The Food and Drug Administration has launched a campaign designed to educate consumers about online rogue pharmacies, the agency said Friday.
The FDA announced the launch of BeSafeRx, which includes resources for patients and caregivers who might purchase medications online.
According to a new FDA survey, nearly one quarter of Internet consumers has purchased prescription drugs online, but nearly 30% said they lacked confidence about how to make safe online purchases. But the risk of purchasing from rogue pharmacies is high, the FDA said, and according to the National Association of Boards of Pharmacy, less than 3% of online pharmacies meet state and federal laws.
"Buying medicines from rogue online pharmacies can be risky because they may sell fake, expired, contaminated, not approved by FDA or otherwise unsafe products that are dangerous to patients," FDA commissioner Margaret Hamburg said. "Fraudulent and illegal online pharmacies often offer deeply discounted products. If the low prices seem too good to be true, they probably are."
Fake pharmacies, according to the FDA, use various means to appear legitimate, but patients should only buy drugs online from pharmacies that require a valid prescription from a doctor or other professional, are located in the United States, have a licensed pharmacist available for consultation and are licensed by the patient’s state board of pharmacy.